Literature DB >> 9454848

Activated protein C reduces the severity of compression-induced spinal cord injury in rats by inhibiting activation of leukocytes.

Y Taoka1, K Okajima, M Uchiba, K Murakami, N Harada, M Johno, M Naruo.   

Abstract

Activated protein C (APC), an important inhibitor of the coagulation system, has recently been shown to prevent tissue injury by blocking the activation of leukocytes. To determine whether APC can also prevent post-traumatic spinal cord injury (SCI), a condition in which leukocytes play an important role, we tested the effects of APC on SCI induced in rats by compression trauma. Administration of APC, either before or after the induction of SCI, markedly reduced the motor disturbances in these animals. In contrast, neither an inactive derivative of activated factor X (DEGR-Xa), a selective inhibitor of thrombin generation, nor active site-blocked APC (DIP-APC) reduced the motor disturbances. Histological examination revealed that intramedullary hemorrhages, observed 24 hr after trauma, were significantly reduced in the animals administered APC. The increase in the tissue level of tumor necrosis factor-alpha (TNF-alpha) and the accumulation of neutrophils in the damaged segment of the spinal cord were significantly inhibited in the animals that had received APC, but these were not inhibited in those administered DIP-APC or DEGR-Xa. The induction of leukocytopenia had the same effect as APC, in that it significantly reduced motor disturbances, tissue levels of TNF-alpha, and neutrophil accumulation in the animals subjected to compressive SCI. These findings suggest that in SCI, APC reduces motor disturbances primarily by reducing the amount of TNF-alpha at the site of injury, thus inhibiting neutrophil accumulation and the resultant damage to the endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9454848      PMCID: PMC6792717     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  31 in total

1.  Objective clinical assessment of motor function after experimental spinal cord injury in the rat.

Authors:  A S Rivlin; C H Tator
Journal:  J Neurosurg       Date:  1977-10       Impact factor: 5.115

Review 2.  Macrophages and inflammatory damage in spinal cord injury.

Authors:  A R Blight
Journal:  J Neurotrauma       Date:  1992-03       Impact factor: 5.269

3.  Secondary CNS injury.

Authors:  W Young
Journal:  J Neurotrauma       Date:  1988       Impact factor: 5.269

Review 4.  Consequences of leukocyte-vessel wall interactions in inflammatory and immune reactions.

Authors:  J M Harlan
Journal:  Semin Thromb Hemost       Date:  1987-10       Impact factor: 4.180

5.  The inhibition of blood coagulation by activated Protein C through the selective inactivation of activated Factor V.

Authors:  F J Walker; P W Sexton; C T Esmon
Journal:  Biochim Biophys Acta       Date:  1979-12-07

6.  Stimulation of neutrophils by tumor necrosis factor.

Authors:  S J Klebanoff; M A Vadas; J M Harlan; L H Sparks; J R Gamble; J M Agosti; A M Waltersdorph
Journal:  J Immunol       Date:  1986-06-01       Impact factor: 5.422

7.  Reperfusion-induced leukocyte infiltration: role of elastase.

Authors:  B J Zimmerman; D N Granger
Journal:  Am J Physiol       Date:  1990-08

8.  Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production.

Authors:  K Murakami; K Okajima; M Uchiba; M Johno; T Nakagaki; H Okabe; K Takatsuki
Journal:  Am J Physiol       Date:  1997-02

9.  Sequential expression of c-fos protooncogene, TNF-alpha, and dynorphin genes in spinal cord following experimental traumatic injury.

Authors:  A G Yakovlev; A I Faden
Journal:  Mol Chem Neuropathol       Date:  1994 Oct-Dec

10.  Polymorphonuclear leukocyte accumulation in inflammatory dermal sites as measured by 51Cr-labeled cells and myeloperoxidase.

Authors:  C Lundberg; K E Arfors
Journal:  Inflammation       Date:  1983-09       Impact factor: 4.092

View more
  12 in total

Review 1.  Neutrophils cascading their way to inflammation.

Authors:  Christian D Sadik; Nancy D Kim; Andrew D Luster
Journal:  Trends Immunol       Date:  2011-08-11       Impact factor: 16.687

Review 2.  Cytoprotective protein C pathways and implications for stroke and neurological disorders.

Authors:  Berislav V Zlokovic; John H Griffin
Journal:  Trends Neurosci       Date:  2011-02-25       Impact factor: 13.837

3.  Activated protein C reduces the ischemia/reperfusion-induced spinal cord injury in rats by inhibiting neutrophil activation.

Authors:  K Hirose; K Okajima; Y Taoka; M Uchiba; H Tagami; K Nakano; J Utoh; H Okabe; N Kitamura
Journal:  Ann Surg       Date:  2000-08       Impact factor: 12.969

4.  Activated protein C analog protects from ischemic stroke and extends the therapeutic window of tissue-type plasminogen activator in aged female mice and hypertensive rats.

Authors:  Yaoming Wang; Zhen Zhao; Nienwen Chow; Padmesh S Rajput; John H Griffin; Patrick D Lyden; Berislav V Zlokovic
Journal:  Stroke       Date:  2013-10-24       Impact factor: 7.914

5.  The LTB4-BLT1 axis mediates neutrophil infiltration and secondary injury in experimental spinal cord injury.

Authors:  Hirokazu Saiwai; Yasuyuki Ohkawa; Hisakata Yamada; Hiromi Kumamaru; Akihito Harada; Hideyuki Okano; Takehiko Yokomizo; Yukihide Iwamoto; Seiji Okada
Journal:  Am J Pathol       Date:  2010-03-19       Impact factor: 4.307

6.  Activated protein C analog with reduced anticoagulant activity improves functional recovery and reduces bleeding risk following controlled cortical impact.

Authors:  Corey T Walker; Andrew H Marky; Anthony L Petraglia; Tracy Ali; Nienwen Chow; Berislav V Zlokovic
Journal:  Brain Res       Date:  2010-06-01       Impact factor: 3.252

Review 7.  An update on spinal cord injury research.

Authors:  He-Qi Cao; Er-Dan Dong
Journal:  Neurosci Bull       Date:  2012-11-03       Impact factor: 5.203

Review 8.  [Mechanisms of action of recombinant human activated Protein C].

Authors:  M Brueckmann; G Huhle; M Max
Journal:  Anaesthesist       Date:  2006-06       Impact factor: 1.041

Review 9.  The normal role of Activated Protein C in maintaining homeostasis and its relevance to critical illness.

Authors:  C T Esmon
Journal:  Crit Care       Date:  2001       Impact factor: 9.097

10.  Recombinant human activated protein C resets thrombin generation in patients with severe sepsis - a case control study.

Authors:  Anne-Cornélie J M de Pont; Kamran Bakhtiari; Barbara A Hutten; Evert de Jonge; Margreeth B Vroom; Joost C M Meijers; Harry R Büller; Marcel Levi
Journal:  Crit Care       Date:  2005-07-21       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.